EDMONTON, Jan. 4 /CNW/ - Ceapro Inc. (TSX-V: CZO) today announced the establishment of Ceapro BioEnergy Inc. (CBE), a wholly-owned subsidiary to utilize Ceapro's proprietary technology for the production of ethanol and value-added products.
"Ceapro has recognized that our core processing and extraction technology is directly applicable to the production of green renewable fuels such as ethanol," stated Dr. Mark Redmond, President and CEO of Ceapro. "The recent directive from the Canadian Federal Government requiring the incorporation of 5% renewable content in gasoline by 2010 confirmed that we will have a market for ethanol. In addition, the Alberta Government has committed a total of $269 million to develop the province's renewable fuels industry and to support technology investment. The combined factors of our technology, an immediate market, and government support provide Ceapro with a significant business opportunity". Dr. Redmond also praised the Federal and Alberta Governments for providing the appropriate economic environment to allow biotechnologies such as Ceapro to thrive.
To begin operations, CBE has received a conditional award for $300,000 from the Federal Government Biofuels Opportunities for Producers Initiative (BOPI) program. The non-repayable funding will support a feasibility study for the construction and operation of a biorefinery and processing plant. Should the feasibility study prove favourable, Ceapro will work in partnership with fuel distributors and commence plant construction with a projected opening in 2008.
Since 1992, Ceapro has worked in the grain processing and value-added industries, and as a result has acquired business acumen, scientific expertise, and technology which are directly applicable to the development of a new and integrated approach to bioenergy production. The bioenergy industry works in tandem with the agriculture industry to add value to crops, to expand markets, to create jobs, and to support the diversification of rural economies, thus protecting rural life and rural communities.
About Ceapro Inc.
Ceapro Inc. is a growth stage biotechnology company. Ceapro's core technology is the extraction of functional, active ingredients. We will continue to add value to our extracts by manufacturing medical and therapeutic products, support the use of our extracts in products for human and animal health, and introduce health and wellness services employing our CeaProve(R) diagnostic technology. Ceapro shares trade on the TSX Venture Exchange under the symbol CZO. To learn more about Ceapro, visit our website at www.ceapro.com. Shares Outstanding: 37,505,505, Recent Close: $0.26
The TSX Venture Exchange has not reviewed and does not accept
responsibility for the adequacy or the accuracy of this news release.
This release may contain forward-looking statements. Various factors could cause actual results to differ materially from those projected in forward-looking statements. Although the Company believes that the forward-looking statements contained herein are reasonable, it can give no assurance that the Company's expectations are correct. All forward-looking statements are expressly qualified in their entirety by this cautionary statement.
%SEDAR: 00010110E